Table 3.
CVH Strata |
|||||||
---|---|---|---|---|---|---|---|
All Favorable | 1+ Elevated, None High | 1 High | 2 + High | P-value | |||
Sample Characteristics: | |||||||
Avg. Age at Follow-up (years) | 74.5 | 75.8 | 76.0 | 76.3 | <0.001 | ||
Female, % | 61.9 | 41.1 | 41.6 | 36.6 | <0.001 | ||
White, % | 88.2 | 91.5 | 90.6 | 90.7 | 0.194 | ||
Black, % | 6.3 | 5.2 | 6.6 | 6.9 | 0.005 | ||
Avg. Age at CV Risk Measurement (years) | 37.9 | 41.2 | 42.5 | 44.3 | <0.001 | ||
With a High School Degree, % | 34.6 | 34.6 | 38.5 | 39.9 | <0.001 | ||
With a More than High School Degree, % | 55.6 | 52.0 | 43.6 | 35.7 | <0.001 | ||
Utilization and Costs: | |||||||
Avg. No. of Acute Inpatient Admissions | 0.19 | 0.24 | 0.29 | 0.38 | <0.001 | ||
Avg. Acute Inpatient Length of Stay (days) | 0.91 | 1.2 | 1.6 | 2.1 | <0.001 | ||
Avg. No. of Post-acute inpatient admissions | 0.04 | 0.04 | 0.05 | 0.07 | <0.001 | ||
Avg. Post-acute inpatient Length of Stay (days) | 0.97 | 1.3 | 1.5 | 1.9 | <0.001 | ||
Avg. No. of Ambulatory Care Visits | 14.6 | 15.4 | 15.8 | 17.1 | <0.001 | ||
Avg. No. of Home Health Visits | 1.4 | 2.0 | 2.5 | 3.8 | <0.001 | ||
Total Costs, $ | Median | 1,548 | 1,819 | 1,854 | 2,241 | <0.001 | |
Mean | 6,903 | 8,312 | 9,613 | 12,111 | <0.001 | ||
Acute Inpatient Costs, $ | Median | 0 | 0 | 0 | 0 | − | |
Mean | 2,601 | 3,378 | 4,202 | 5,742 | <0.001 | ||
Post-acute Inpatient Costs, $ | Median | 0 | 0 | 0 | 0 | − | |
Mean | 454 | 628 | 746 | 948 | <0.001 | ||
Ambulatory Care Costs, $ | Median | 1,464 | 1,679 | 1,665 | 1,906 | <0.001 | |
Mean | 3,343 | 3,631 | 3,806 | 4,298 | <0.001 | ||
Home Health Care Costs, $ | Median | 0 | 0 | 0 | 0 | − | |
Mean | 317 | 405 | 498 | 723 | <0.001 | ||
Other Costs*, $ | Median | 0 | 0 | 0 | 0 | − | |
Mean | 187 | 270 | 361 | 401 | <0.001 | ||
Sample Size (person-year) | 8,226 | 34,945 | 64,980 | 50,155 | <0.001 | ||
Number of CHA Participants | 951 | 3,496 | 7,040 | 5,708 | <0.001 |
Notes: Total sample size is 158,306 person-years. Costs are measured in 2016 dollars. P-values are obtained from Wald tests for the equality of the sample characteristics among the four risk strata.
*Other costs include costs for hospice care and durable medical equipment.